Transdermal delivery of tea catechins by electrically assisted methods

Skin Pharmacology and Physiology

Volumn 19, Issue 1, 2005, Pages 28-37

  Fang, J Y ^a   Hung, C F ^b   Hwang, T L ^a   Wong, W W ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Electroporation; In vitro; Iontophoresis; Tea catechins; Transdermal delivery

Indexed keywords

CATECHIN; EPICATECHIN; EPIGALLOCATECHIN GALLATE; GALLIC ACID DERIVATIVE; LIPID; LIPOSOME;

ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TRANSPORT; ELECTRIC CONDUCTIVITY; ELECTROPORATION; FUSION GENE; HYDRATION; IONTOPHORESIS; ISOMER; NONHUMAN; PH; PRIORITY JOURNAL; SKIN; SKIN ABSORPTION; SKIN FUNCTION; SKIN PERMEABILITY; SKIN WATER LOSS; STRATUM CORNEUM; SWINE; TEA; TECHNIQUE;

ADMINISTRATION, CUTANEOUS; ANIMALS; CATECHIN; ELECTRIC CONDUCTIVITY; ELECTROPORATION; IONTOPHORESIS; LIPOSOMES; SKIN ABSORPTION; SWINE; TEA;

EID: 28744438394     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089141     Document Type: Article

References (30)

1. Cai Y, Anavy ND, Chow HSS: Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats. Drug Metab Dispos 2002;30:1246-1249.
2. Katiyar SK, Ahmad N, Mukhtar H: Green tea and skin. Arch Dermatol 2000;136:989-994.
3. Baba S, Osakabe N, Natsume M, Muto Y, Takizawa T, Terao J: In vivo comparison of the bioavailability of (+)-catechin, (-)-epicatechin and their mixture in orally administered rats. J Nutr 2001;131:2885-2891.
4. 3H-labelled tea antioxidants (+)-catechin and (-)-epicatechin in rat. Xenobiotica 2003;33:743-753.
5. Banga AK, Bose S, Ghosh TK: Iontophoresis and electroporation: comparisons and contrasts. Int J Pharm 1999;179:1-19.
6. Jadoul A, Bouwstra J, Préat V: Effects of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies. Adv Drug Deliv Rev 1999;35:89-105.
7. Blache D, Durand P, Prost M, Loreau N: (+)-Catechin inhibits platelet hyperactivity induced by an acute iron load in vivo. Free Radic Biol Med 2002;33:1670-1680.
8. Merino V, López A, Kalia YN, Guy RH: Electroporation versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm Res 1999;16:758-761.
9. Wertz PW, Abraham W, Landmann L, Downing DT: Preparation of liposomes from stratum corneum lipids. J Invest Dermatol 1986;87:582-584.
10. Soleas GJ, Grass L, Josephy PD, Goldberg DM, Diamandis EP: A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin Biochem 2002;35:119-124.
11. Jadoul A, Lecouturier N, Mesens J, Caers W, Préat V: Transdermal alniditan delivery by skin electroporation. J Control Release 1998;54:265-272.
12. Bose S, Ravis WR, Lin YJ, Zhang L, Hofmann GA, Banga AK: Electrically-assisted transdermal delivery of buprenorphine. J Control Release 2001;73:197-203.
13. Prausnitz MR: Do high-voltage pulses cause changes in skin structure? J Control Release 1996;40:321-326.
14. Fang JY, Hung CF, Fang YP, Chan TF: Transdermal iontophoresis of 5-fluorouracil combined with electroporation and laser treatment. Int J Pharm 2004;270:241-249.
15. Denet A, Vanbever R, Préat V: Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev 2004;56:659-674.
16. Zhu QY, Holt RR, Lazarus SA, Ensunsa JL, Hammerstone TF, Schmitz HH, Keen CL: Stability of the flavan-3-ols epicatechin and catechin and related dimeric procyanidins derived from cocoa. J Agric Food Chem 2002;50:1700-1705.
17. Murthy SN, Sen A, Zhao YL, Hui SW: pH influences the postpulse permeability state of skin after electroporation. J Control Release 2003;93:49-57.
18. Dreosti IE: Antioxidant polyphenols in tea, cocoa, and wine. Nutrition 2000;16:692-694.
19. Batchelder RJ, Calder RJ, Tomas CP, Heard CM: In vitro transdermal delivery of the major catechins and caffeine from extract of Camellia sinensis. Int J Pharm 2004;283:45-51.
20. Hashimoto T, Kumazawa S, Nanjo F, Hara Y, Nakayama T: Interaction of tea catechins with lipid bilayers investigated with liposome systems. Biosci Biotechnol Biochem 1999;63:2252-2255.
21. Stinchcomb A, Pliwal A, Dua R, Imoto H, Woodard RW, Flynn GL: Permeation of buprenorphine and its ester prodrugs through skin. Pharm Res 1996;13:1519-1523.
22. Sung KC, Fang JY, Wang JJ, Hu OYP: Transdermal delivery of nalbuphine and its prodrugs by electroporation. Eur J Pharm Sci 2003;18:63-70.
23. Mitragotri S: Synergistic effect of enhancers for transdermal drug delivery. Pharm Res 2000;17:1354-1359.
24. Vanbever R, De Morre N, Préat V: Transdermal delivery of fentanyl by electroporation. II. Mechanisms involved in drug transport. Pharm Res 1996;13:1360-1366.
25. Marro D, Guy RH, Charro MB: Characterization of the iontophoretic permselectivity properties of human and pig skin. J Control Release 2001;70:213-217.
26. Prausnitz MR, Lee CS, Liu CH, Pang JC, Singh T, Langer R, Weaver JC: Transdermal transport efficiency during skin electroporation and iontophoresis. J Control Release 1996;38:25-217.
27. Zhao K, Singh J: Mechanisms of in vitro percutaneous absorption enhancement of tamoxifen by enhancers. J Pharm Sci 2000;89:771-780.
28. Fouchard D, Hueber F, Teillaud E, Marty JP: Effects of iontophoretic current flow on hairless rat skin in vivo. J Control Release 1997;49:89-94.
29. Turner NG, Kalia YN, Guy RH: The effect of current on skin barrier function in vivo: recovery kinetics post-iontophoresis. Pharm Res 1997;14:1252-1257.
30. Gallo SA, Sen A, Hensen ML, Hui SW: Time-dependent ultrastructural changes in porcine stratum corneum following an electric pulse. Biophys J 1999;76:2824-2832.